menu
    • menu

    Company profile for Shanghai Yingli Pharmaceutical

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Shanghai Yingli Pharmaceutical Co., Ltd. is an innovative pharmaceutical company founded in 2011 and located in Zhangjiang High-Tech Park, Pudong New Area, Shanghai, China. With the aim to build an internationally recognized innovative pharmaceutical company, we are dedicated to serving unmet medical needs of patients and focus on discovery and development of innovative, best-in-class small molecule drugs for the treatment of ...
    Shanghai Yingli Pharmaceutical Co., Ltd. is an innovative pharmaceutical company founded in 2011 and located in Zhangjiang High-Tech Park, Pudong New Area, Shanghai, China. With the aim to build an internationally recognized innovative pharmaceutical company, we are dedicated to serving unmet medical needs of patients and focus on discovery and development of innovative, best-in-class small molecule drugs for the treatment of cancer, autoimmune diseases and metabolic disorders. During the past years, Yingli Pharma has established an efficient drug R&D team and developed several innovative drug candidates being evaluated in clinical stage.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Shanghai Yingli PharmaceuticalChina Flag
    Country
    Country
    China
    Address
    Address
    Room 01. 4th Floor, Building A, 2829 Jinke Road, Zhangjiang Hi-tech Park, Pudo...
    Telephone
    Telephone
    (86)21-50200003
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.yl-pharma.com/en/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Yingli Pharma's Linperlisib Phase 3 Study Design Cleared by FDA
    Yingli Pharma's Linperlisib Phase 3 Study Design Cleared by FDA

    01 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/yingli-pharma-announces-successful-end-of-phase-2-meeting-with-fda-and-clearance-of-global-multi-center-phase-3-registration-study-design-of-linperlisib-for-the-treatment-of-relapsed-andor-refractory-peripheral-t-cell-lymphoma-302416397.html

    PR NEWSWIRE
    01 Apr 2025
    Share Share
    Yingli Pharma presents a pivotal Phase 2 study data evaluating linperlisib
    Yingli Pharma presents a pivotal Phase 2 study data evaluating linperlisib

    11 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/yingli-pharma-presents-a-pivotal-phase-2-study-data-evaluating-linperlisib-in-relapsed-or-refractory-peripheral-t-cell-lymphoma-in-an-oral-session-at-the-american-society-of-hematology-2023-annual-meeting-302010879.html

    PR NEWSWIRE
    11 Dec 2023
    Share Share
    Yingli Pharma Announces First Patient Dosed in PII Trial of Linperlisib
    Yingli Pharma Announces First Patient Dosed in PII Trial of Linperlisib

    03 Sep 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/yingli-pharma-announces-first-patient-dosed-in-phase-2-trial-of-linperlisib-for-peripheral-t-cell-lymphoma-301617369.html

    PRNEWSWIRE
    03 Sep 2022
    Share Share
    Yingli Pharma, MD Anderson Collaborate for Multiple Oncology Programs
    Yingli Pharma, MD Anderson Collaborate for Multiple Oncology Programs

    20 Jan 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/01/20/2370411/0/en/Yingli-Pharma-and-MD-Anderson-Initiate-Strategic-Collaboration-to-Advance-Development-of-Multiple-Oncology-Programs.html

    GLOBENEWSWIRE
    20 Jan 2022
    Share Share
    Yingli Pharma Announces presentation on Phase 2 clinical trial of linperlisib
    Yingli Pharma Announces presentation on Phase 2 clinical trial of linperlisib

    10 Jun 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/yingli-pharma-announces-a-presentation-on-the-phase-2-clinical-trial-of-linperlisib-a-pi3k-selective-inhibitor-in-relapsed-or-refractory-follicular-lymphoma-at-the-european-hematology-association-2021-congress-301310715.html

    PRNEWSWIRE
    10 Jun 2021
    Share Share
    Yingli Pharma Announces presentation on Phase 2 clinical trial of linperlisib
    Yingli Pharma Announces presentation on Phase 2 clinical trial of linperlisib

    10 Jun 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/yingli-pharma-announces-a-presentation-on-the-phase-2-clinical-trial-of-linperlisib-a-pi3k-selective-inhibitor-in-relapsed-or-refractory-follicular-lymphoma-at-the-european-hematology-association-2021-congress-301310715.html

    PRNEWSWIRE
    10 Jun 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search